Pfizer terminated partnership with Sangamo on hemophilia A gene therapy despite positive Phase 3 data. Find out why SGMO ...
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research ...
GeneDx is targeting a big market for its genetic testing: every newborn baby. The 24-old-company is developing a plan to make the testing common at birth. The goal: Identify potential ...
Lynn Heflin, who was part of the men's Wake Forest basketball program for 35 years as an administrative assistant, will be ...
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results